These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 4164676)

  • 1. Studies on the metabolic error in Refsum's disease.
    Steinberg D; Mize CE; Avigan J; Fales HM; Eldjarn L; Try K; Stokke O; Refsum S
    J Clin Invest; 1967 Mar; 46(3):313-22. PubMed ID: 4164676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of the oxidative defect in phytanic acid degradation in patients with Refsum's disease.
    Mize CE; Herndon JH; Blass JP; Milne GW; Follansbee C; Laudat P; Steinberg D
    J Clin Invest; 1969 Jun; 48(6):1033-40. PubMed ID: 4181594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refsum's disease: nature of the enzyme defect.
    Steinberg D; Herndon JH; Uhlendorf BW; Mize CE; Avigan J; Milne GW
    Science; 1967 Jun; 156(3783):1740-2. PubMed ID: 4180573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absorption of chlorophyll phytol in normal man and in patients with Refsum's disease.
    Baxter JH
    J Lipid Res; 1968 Sep; 9(5):636-41. PubMed ID: 4177872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo study of phytanic acid alpha-oxidation in classic Refsum's disease and chondrodysplasia punctata.
    ten Brink HJ; Schor DS; Kok RM; Stellaard F; Kneer J; Poll-The BT; Saudubray JM; Jakobs C
    Pediatr Res; 1992 Nov; 32(5):566-70. PubMed ID: 1282700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisomal functions in classical Refsum's disease: comparison with the infantile form of Refsum's disease.
    Wanders RJ; Heymans HS; Schutgens RB; Poll-Thé BT; Saudubray JM; Tager JM; Schrakamp G; van den Bosch H
    J Neurol Sci; 1988 Apr; 84(2-3):147-55. PubMed ID: 2454298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phytyl fatty acid esters in vegetables pose a risk for patients suffering from Refsum's disease.
    Krauß S; Michaelis L; Vetter W
    PLoS One; 2017; 12(11):e0188035. PubMed ID: 29131855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in sterol and phospholipid fatty acid composition in Refsum's disease fibroblasts grown in the presence of phytol.
    Friedman KJ; Shapiro SS
    Clin Physiol Biochem; 1985; 3(5):249-56. PubMed ID: 2414050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fatty acid composition of skin and plasma lipids in Refsum's disease.
    Reynolds DJ; Marks R; Davies MG; Dykes PJ
    Clin Chim Acta; 1978 Dec; 90(2):171-7. PubMed ID: 82497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disorders related to the metabolism of phytanic acid.
    Stokke O; Skjeldal OH; Høie K
    Scand J Clin Lab Invest Suppl; 1986; 184():3-10. PubMed ID: 2438746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma exchange for Refsum's disease.
    Gibberd FB
    Transfus Sci; 1993 Jan; 14(1):23-6. PubMed ID: 10150979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phytol and phytanic acid in 2 cases of hereditary chronic polyneuropathy with uncertain classification: correlations with Refsum's disease].
    Livrea P
    Acta Neurol (Napoli); 1973; 28(1):47-59. PubMed ID: 4122245
    [No Abstract]   [Full Text] [Related]  

  • 13. Refsum's disease: defective oxidation of phytanic acid in tissue cultures derived from homozygotes and heterozygotes.
    Herndon JH; Steinberg D; Uhlendorf BW
    N Engl J Med; 1969 Nov; 281(19):1034-8. PubMed ID: 4188238
    [No Abstract]   [Full Text] [Related]  

  • 14. Elucidation of the metabolic error in Refsum's disease: strategy and tactics.
    Steinberg D
    Adv Neurol; 1978; 21():113-24. PubMed ID: 83783
    [No Abstract]   [Full Text] [Related]  

  • 15. Accumulation and defective beta-oxidation of very long chain fatty acids in Zellweger's syndrome, adrenoleukodystrophy and Refsum's disease variants.
    Poulos A; Singh H; Paton B; Sharp P; Derwas N
    Clin Genet; 1986 May; 29(5):397-408. PubMed ID: 2427264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Refsum's disease: characterization of the enzyme defect in cell culture.
    Herndon JH; Steinberg D; Uhlendorf BW; Fales HM
    J Clin Invest; 1969 Jun; 48(6):1017-32. PubMed ID: 4181593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-oxidation as an alternative pathway for the degradation of branched-chain fatty acids in man, and its failure in patients with Refsum's disease.
    Stokke O; Try K; Eldjarn L
    Biochim Biophys Acta; 1967 Oct; 144(2):271-84. PubMed ID: 4168936
    [No Abstract]   [Full Text] [Related]  

  • 18. Phytanic acid in patients with Refsum's syndrome and response to dietary treatment.
    Steinberg D; Mize CE; Herndon JH; Fales HM; Engel WK; Vroom FQ
    Arch Intern Med; 1970 Jan; 125(1):75-87. PubMed ID: 4188898
    [No Abstract]   [Full Text] [Related]  

  • 19. Nutritional and metabolic aspects of heredopathia atactica polyneuritiformis (Refsum's syndrome).
    Lenk W
    Nutr Metab; 1974; 16(6):366-74. PubMed ID: 4135766
    [No Abstract]   [Full Text] [Related]  

  • 20. Tissue distribution of phytanic acid and its analogues in a kinship with Refsum's disease.
    Yao JK; Dyck PJ
    Lipids; 1987 Feb; 22(2):69-75. PubMed ID: 2436023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.